A disease state approach to the pharmacological management of Type 2 diabetes in primary care: A position statement by Primary Care Diabetes Europe

Sadeleştirilmiş öğe sayfası
dc.contributor.authorSeidu, S.
dc.contributor.authorCos, X.
dc.contributor.authorBrunton, S.
dc.contributor.authorHarris, S. B.
dc.contributor.authorJansson, S. P. O.
dc.contributor.authorMata\\-Cases, M.
dc.contributor.authorNeijens, A. M. J.
dc.contributor.authorTopsever, P.
dc.contributor.authorKhunti, K.
dc.date.accessioned2025-10-16T15:19:51Z
dc.date.issued2021
dc.identifier.doi10.1016/j.pcd.2020.05.004
dc.identifier.otherWOS:000604616900010
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7417
dc.publisherELSEVIER SCI LTD
dc.sourcePRIMARY CARE DIABETES
dc.subjectType 2 diabetes
dc.subjectCardiovascular disease
dc.subjectCardiovascular risk factors
dc.subjectMultimorbidity
dc.subjectTherapeutic inertia
dc.subjectHeart failure
dc.subjectChronic kidney disease
dc.subjectElderly
dc.subjectPrimary care
dc.subjectPatient\\-centred care
dc.subjectShared decision making
dc.titleA disease state approach to the pharmacological management of Type 2 diabetes in primary care: A position statement by Primary Care Diabetes Europe
dc.typeReview

Dosyalar

Koleksiyonlar

WOS